Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2026-03-01 @ 6:02 AM
Study NCT ID:
NCT02840032
Status:
WITHDRAWN
Last Update Posted:
2018-05-03
First Post:
2016-07-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Determination of Pneumothorax Post Lung Biopsy
Sponsor:
University of Minnesota
Organization:
Study Overview
Official Title:
Role of Ultrasonography in the Diagnosis of Pneumothorax Following Transbronchial Biopsy in LungTransplant Patients.
Status:
WITHDRAWN
Status Verified Date:
2018-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No subjects enrolled
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Bedside ultrasonography for detection of pneumothorax after transbronchial lung biopsies in lung transplant patients
Detailed Description:
The patients who undergo transbronchial forceps lung biopsies get a routine CXR after the biopsies are performed. The reason for CXR is to find out if pneumothorax occurred or not. CXR is required patient transportation and interpretation by the radiologist as well as time consuming. Instead, we are planning to perform bedside ultrasound to determine if pneumothorax occurred or not
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: